INSULIN GLARGINE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Insulin Glargine Market, By Type (Lantus, Basaglar, Toujeo, Soliqua/Suliqua, Others), By Diabetes Type (Type 2 Diabetes, Type 1 Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In: 03 Apr, 2026
Code: CMI5231
Page number: 167
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Type
  - Market Snapshot, By Diabetes Type
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Increasing prevalence of diabetes worldwide
  - High cost of insulin glargine
  - Increase in awareness about diabetes management
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Global Insulin Glargine Market, By Type, 2021 - 2033, (USD BN)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- Lantus
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD BN)
- Basaglar
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD BN)
- Toujeo
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD BN)
- Soliqua/Suliqua
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD BN)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD BN)
Global Insulin Glargine Market, By Diabetes Type, 2021 - 2033, (USD BN)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- Type 2 Diabetes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD BN)
- Type 1 Diabetes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD BN)
Global Insulin Glargine Market, By Distribution Channel, 2021 - 2033, (USD BN)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD BN)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD BN)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD BN)
Global Insulin Glargine Market, By Region, 2021 - 2033, (USD BN)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- North America
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Diabetes Type, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD BN)
    - U.S.
    - Canada
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Diabetes Type, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Diabetes Type, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD BN)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Diabetes Type, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD BN)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Diabetes Type, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD BN)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Diabetes Type, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD BN)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Diabetes Type, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD BN)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Biocon
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Eli Lilly and Company
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Boehringer Ingelheim
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Gan & Lee
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Kalbe Pharma
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Polus Biopharm
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Samsung Bioepis
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Wockhardt
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novo Nordisk AS
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Julphar
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Viatris Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

*Browse 24 market data tables and 28 figures on "Global Insulin Glargine Market” –forecast to 2033

Instant Download - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now